by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
ATLANTA, Sept. 14, 2016 (GLOBE NEWSWIRE) — Aviragen Therapeutics, Inc. (NASDAQ:AVIR) today announced its financial results for the fourth quarter and 2016 fiscal year ended June 30, 2016, and also provided an update on recent corporate and clinical developments....
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
CAMBRIDGE, Mass., Sept. 14, 2016 (GLOBE NEWSWIRE) — Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis, today...
by GlobeNewsWire | Sep 14, 2016 | Feature Box, Featured, FP, Globe Newswire
NEW YORK, Sept. 14, 2016 (GLOBE NEWSWIRE) — Aspen Group, Inc. (OTCQB:ASPU) (“Aspen”), a nationally accredited online post-secondary education company (Aspen University), today announced financial results for its 2017 fiscal first quarter ended July 31, 2016. The...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet need, today...
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SAN JOSE, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Apigee® (NASDAQ:APIC), the API company, today announced financial results for its fourth quarter and fiscal year ended July 31, 2016. Fiscal Year 2016 For FY 16, Apigee reported total revenue of $92.0 million,...